Michael F. Mahoney has been the CEO of Boston Scientific Corp. since 2011, steering the company towards innovative medical device solutions. He has a strong background in the medical field, previously holding senior roles at Johnson & Johnson. With a...

Michael F. Mahoney has been the CEO of Boston Scientific Corp. since 2011, steering the company towards innovative medical device solutions. He has a strong background in the medical field, previously holding senior roles at Johnson & Johnson. With a finance degree from the University of Iowa and an MBA from Wake Forest University, he combines technical knowledge with a business mind. Mahoney owns over $109 million in Boston Scientific shares, highlighting his belief in the company’s future. His annual pay in 2023 was over $18 million, which included a base salary of $1.4 million and performance bonuses. In his time as CEO, he has focused on driving growth and maximizing shareholder value while maintaining a rigorous performance-based compensation system. Under his leadership, Boston Scientific has navigated significant market challenges and emerged stronger, emphasizing long-term sustainability. Mahoney is also prepared for changes, with solid severance plans in place. A leader who values performance, he continues to drive Boston Scientific in its mission to deliver less invasive healthcare solutions around the globe.